Markets.com Logo

IPH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.9562$
  • Previous Close
    2.0177$
  • 52 Week Change
    1.17$
  • Day Range
    -0.06$
  • 52 Week High/Low
    1.33$ - 2.5$
  • Dividend Per Share
    --
  • Market cap
    186 M$
  • EPS
    -0.3
  • Beta
    0.925
  • Volume
    --

About

IPH.PA is the stock ticker symbol for Ipsen SA, a French multinational pharmaceutical company. Ipsen focuses on three specialty care therapeutic areas: oncology, neuroscience, and rare diseases. The company develops and commercializes innovative medicines to address unmet medical needs. IPH.PA is traded on the Euronext Paris stock exchange.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Strong financial results, successful product launches, and positive clinical trial outcomes generally drive the IPH.PA stock price higher.

Market Sentiment: Overall investor confidence in the biotechnology sector and the broader stock market significantly impacts IPH.PA's valuation.

Regulatory Approvals: Key regulatory decisions, such as FDA or EMA approvals for Immutep's drug candidates, can trigger substantial price movements.

Competition: Developments from competing companies in immuno-oncology can influence investor perceptions of Immutep's market position and potential.

Clinical Trial Data: Positive or negative data readouts from clinical trials of Immutep's lead product candidates are critical price determinants.

Partnerships and Collaborations: Strategic collaborations with larger pharmaceutical companies often lead to increased investor interest and higher stock prices.

Macroeconomic Factors: Economic conditions, interest rates, and inflation levels can indirectly affect IPH.PA's stock price by influencing overall market dynamics.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--